Literature DB >> 21870221

RGS-insensitive Gα subunits: probes of Gα subtype-selective signaling and physiological functions of RGS proteins.

Kuljeet Kaur1, Jason M Kehrl, Raelene A Charbeneau, Richard R Neubig.   

Abstract

The Regulator of G protein Signaling (RGS) proteins were identified as a family in 1996 and humans have more than 30 such proteins. Their best known function is to suppress G Protein-Coupled Receptors (GPCR) signaling by increasing the rate of Gα turnoff through stimulation of GTPase activity (i.e., GTPase acceleration protein or GAP activity). The GAP activity of RGS proteins on the Gαi and Gαq family of G proteins can terminate signals initiated by both α and βγ subunits. RGS proteins also serve as scaffolds, assembling signal-regulating modules. Understanding the physiological roles of RGS proteins is of great importance, as GPCRs are major targets for drug development. The traditional method of using RGS knockout mice has provided some information about the role of RGS proteins but in many cases effects are modest, perhaps because of redundancy in RGS protein function. As an alternative approach, we have utilized a glycine-to-serine mutation in the switch 1 region of Gα subunits that prevents RGS binding. The mutation has no known effects on Gα binding to receptor, Gβγ, or effectors. Alterations in function resulting from the G>S mutation imply a role for both the specific mutated Gα subunit and its regulation by RGS protein activity. Mutant rodents expressing these G>S mutant Gα subunits have strong phenotypes and provide important information about specific physiological functions of Gαi2 and Gαo and their control by RGS. The conceptual framework behind this approach and a summary of recent results is presented in this chapter.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870221     DOI: 10.1007/978-1-61779-160-4_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Optogenetic Inhibition of Gαq Protein Signaling Reduces Calcium Oscillation Stochasticity.

Authors:  Pimkhuan Hannanta-Anan; Brian Y Chow
Journal:  ACS Synth Biol       Date:  2018-06-04       Impact factor: 5.110

Review 2.  Thinking outside of the "RGS box": new approaches to therapeutic targeting of regulators of G protein signaling.

Authors:  Benita Sjögren; Richard R Neubig
Journal:  Mol Pharmacol       Date:  2010-07-27       Impact factor: 4.436

Review 3.  Roles for Regulator of G Protein Signaling Proteins in Synaptic Signaling and Plasticity.

Authors:  Kyle J Gerber; Katherine E Squires; John R Hepler
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

Review 4.  R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity.

Authors:  Zhihui Xie; Eunice C Chan; Kirk M Druey
Journal:  AAPS J       Date:  2015-11-23       Impact factor: 4.009

5.  A P-loop mutation in Gα subunits prevents transition to the active state: implications for G-protein signaling in fungal pathogenesis.

Authors:  Dustin E Bosch; Francis S Willard; Ravikrishna Ramanujam; Adam J Kimple; Melinda D Willard; Naweed I Naqvi; David P Siderovski
Journal:  PLoS Pathog       Date:  2012-02-23       Impact factor: 6.823

6.  Regulator of G-protein signaling 18 controls both platelet generation and function.

Authors:  Nathalie Delesque-Touchard; Caroline Pendaries; Cécile Volle-Challier; Laurence Millet; Véronique Salel; Caroline Hervé; Anne-Marie Pflieger; Laurence Berthou-Soulie; Catherine Prades; Tania Sorg; Jean-Marc Herbert; Pierre Savi; Françoise Bono
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

7.  Rgs13 constrains early B cell responses and limits germinal center sizes.

Authors:  Il-Young Hwang; Kyung-Sun Hwang; Chung Park; Kathleen A Harrison; John H Kehrl
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

8.  Inhibition of the Binding between RGS2 and β-Tubulin Interferes with Spindle Formation and Chromosome Segregation during Mouse Oocyte Maturation In Vitro.

Authors:  Man-Xi Jiang; Yan Shi; Zhao-Gui Sun; Zhi Zhang; Yan Zhu
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.